Maxtra-O Nasal Spray
Images are for reference. Actual packaging may vary.
Oxymetazoline (0.05% w/v)
Bottle of 10 ml • Syrup
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Oxymetazoline acts as a vasoconstrictor, reducing blood flow to inflamed areas in the skin.
Medical applications
Maxtra-O Nasal Spray contains Oxymetazoline 0.05% w/v, a topical decongestant indicated for the relief of nasal congestion associated with conditions such as allergic rhinitis, common cold, sinusitis, and hay fever. Oxymetazoline acts as a selective alpha-adrenergic agonist, producing vasoconstriction of the nasal mucosal blood vessels, thereby reducing swelling and congestion.
This mechanism facilitates improved nasal airflow and eases breathing. Maxtra-O Nasal Spray is intended for intranasal administration, with a recommended dosage of one to two sprays in each nostril every 10 to 12 hours, not exceeding two doses in a 24-hour period. Prolonged use beyond three consecutive days is not advised to prevent rebound congestion (rhinitis medicamentosa).
Caution is warranted in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, or prostatic hypertrophy, and consultation with a healthcare professional is recommended prior to use. Adverse effects may include nasal dryness, irritation, sneezing, or transient burning sensation. Maxtra-O Nasal Spray should not be used concurrently with monoamine oxidase inhibitors or within 14 days of their discontinuation.
It is contraindicated in patients with hypersensitivity to Oxymetazoline or any formulation components. Proper use of Maxtra-O Nasal Spray provides rapid and effective symptomatic relief of nasal congestion.
Imidazole Derivative
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Maxtra-O Nasal Spray may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Maxtra-O Nasal Spray is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. To reduce the amount of Maxtra-O Nasal Spray that reaches the breastmilk, remove the excess solution with an absorbent tissue.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Maxtra-O Nasal Spray







